Video Experimental Relacionado
Updated: May 5, 2026
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
25.1K
Pequeños accidentes cerebrovasculares, gran impacto: mortalidad excesiva después de un accidente cerebrovascular
Lee E Neilson1,2,3, Chen Lin4,5, Anusha Mishra1
1Department of Neurology, Oregon Health & Science University, Portland, Oregon, USA.
Movement disorders : official journal of the Movement Disorder Society
|February 10, 2026
Resumen
Los pacientes con enfermedad de Parkinson (EP) y accidente cerebrovascular isquémico agudo (EIA) se enfrentan a una mortalidad significativamente mayor. Este aumento del riesgo es independiente de otras condiciones de salud, lo que sugiere la necesidad de tratamientos dirigidos para los pacientes con accidente cerebrovascular PD.
Área de la Ciencia:
- Neurología Neurología.
- Gerontología Gerontología.
- Salud Pública La salud pública.
Sus antecedentes:
- El accidente cerebrovascular isquémico agudo (AIS) en pacientes con enfermedad de Parkinson (EP) presenta un desafío creciente para la salud pública.
- Existe una investigación limitada sobre las tasas de mortalidad para esta población específica de pacientes.
Objetivo del estudio:
- Para analizar las tasas de supervivencia a corto y largo plazo en pacientes con PD y AIS.
- Estratificar los resultados de la supervivencia en función de las características de las comorbilidades y del accidente cerebrovascular.
Principales métodos:
- Utilizó datos de la Administración de Salud de Veteranos de los Estados Unidos.
- AIS y PD definidos utilizando códigos ICD validados y otros registros de salud.
- Se emparejó 3173 casos de PD + AIS 4: 1 con grupos de solo PD, solo accidente cerebrovascular y grupos de control para el análisis de supervivencia a 10 años.
- Se revisaron las características del accidente cerebrovascular (tamaño, ubicación, mecanismo) para un subconjunto de casos.
Principales resultados:
- Los pacientes con PD + AIS presentaron una mortalidad significativamente mayor en comparación con los grupos de solo PD, solo accidente cerebrovascular y grupos de control.
- Este aumento de la mortalidad mostró patrones distintos en períodos de 0-1, 1-5 y 5-10 años, lo que indica efectos sinérgicos.
- El mayor riesgo persistió incluso después de tener en cuenta las comorbilidades cardiovasculares, el neurotrauma y la fragilidad.
- Los pacientes con EIA PD + tendían a tener accidentes cerebrovasculares más pequeños que los pacientes solo con accidente cerebrovascular, con ubicación, mecanismo y tasas de recurrencia similares.
Conclusiones:
- Los pacientes con PD y AIS experimentan una mortalidad mayor de lo esperado, independientemente de las comorbilidades o los detalles del accidente cerebrovascular.
- Este hallazgo sugiere déficits sistémicos subyacentes en pacientes con EP que exacerban los resultados del accidente cerebrovascular.
- Un enfoque terapéutico especializado puede ser necesario para el manejo de AIS en individuos con enfermedad de Parkinson.
Videos de Conceptos Relacionados
01:15Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
01:24Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
01:15Ischemic Stroke ll: Pathophysiology
68
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
68
01:29Hemorrhagic Stroke ll: Pathophysiology
52
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
52
01:24Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
01:24Parkinson Disease ll: Pathophysiology
34
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
34